Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity.
Epidemiological studies demonstrate an association between insulin resistance, hypertension and cardiovascular morbidity. In addition to its metabolic effects, insulin also has important cardiovascular actions. The sympathetic nervous system and the nitric oxide-l-arginine pathway have emerged as central players in the mediation of these actions. Over the past decade, the underlying mechanisms and the factors that may govern the interaction between insulin and these two major cardiovascular regulatory systems have been studied extensively in healthy people and insulin-resistant individuals. Here we summarize the current understanding and gaps in knowledge on these interactions. We propose that a genetic and/or acquired defect of nitric oxide synthesis could represent a central defect triggering many of the metabolic, vascular and sympathetic abnormalities characteristic of insulin-resistant states, all of which may predispose to cardiovascular disease.
Scherrer
U
U
Department of Internal Medicine and Botnar Centre for Clinical Research, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. Urs.Scherrer@chuv.hospvd.ch
Sartori
C
C
D002318:Cardiovascular Diseases / Q000209:etiology*; D006801:Humans; D007333:Insulin Resistance; D009569:Nitric Oxide / Q000096:biosynthesis*; D013564:Sympathetic Nervous System / Q000503:physiopathology*
D009569:Nitric Oxide